Oramed Pharmaceutical Inc. Technology and Politics Essay -- Business A

Oramed Pharmaceutical Inc. applied scienceOramed is a contemporary pharmaceutical beau monde that is mainly focused into developing new-fashioned cutting-edge medicinal diabetic drugs that have not been in reality before. Similar to other pharmaceutical companies, engine room is a key factor in the success such companies. In an exclusive interview on www. fence inst.net with Nadav Kidron, Orameds CEO, he was quoted describing Oramed Pharmaceuticals Inc. as an Israeli company focused on the development of oral delivery solutions based on proprietary technology (PR Newswire Association LLC, 2007). Kidrons comment demonstrates the value of technology to Oramed causing the company to patent its technology and crossing. Lately Oramed focused on the development of a new diabetic drug called ORMD0801. This product, in a form of a gel capsule, can be consumed orally. ORMD0801 in turn, plays a role in eliminating the need for insulin delivery by the means of self-injecting and constant painful examen of insulin blood levels. In order to accomplish this function, Oramed will need innovative technology and certainly top-notch high-tech equipment. Therefore, Oramed has to in an ongoing basis to control in-licensing and other means of obtaining additional technologies to complement and/or expand its product portfolio (The New York Times, 2012).Orameds emerging ORMD0801 delivery is a technology in its-self. It advances the ability of the body to absorb peptides and proteins through the intestinal track wall without creating any changes to the active ingredients of the drug (Oramed, 2009). This was possible by introducing a reticence drug delivery system (Oramed Pharmaceuticals Inc., 2010). This delivery system will successfully deliver the drug to ... ...012/03/20/idUS125396+20-Mar-2012+BW20120320 PR Newswire Association LLC. (2007). Exclusive query With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net. PR Newswire. ProQuest Newsstand. http//pr oquest.umi.com/pqdlink?vinst=PROD&fmt=3&startpage=-1&vname=PQD&RQT=309&did=1256371181&scaling= blanket(a)&vtype=PQD&rqt=309&TS=1333335886&clientId=20655PR Newswire Association LLC. (2009). Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award. PR Newswire. http//proquest.umi.com.ezproxy.liberty.edu2048/pqdlink?vinst=PROD&fmt=3&startpage=1&vname=PQD&RQT=309&did=1844533951&scaling=FULL&vtype=PQD&rqt=309&TS=1333049930&clientId=20655The New York Times. (2012). Business Day. Retrieved from NY Times.com http//topics.nytimes.com/top/news/business/companies/oramed-pharmaceuticals-inc/index.html